iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Mankind Pharma files DRHP for Rs 5,500 crore IPO

19 Sep 2022 , 08:09 AM

Mankind Pharma, the drugmaker behind Manforce Condoms and Prega News, has filed its draft red herring prospectus (DRHP) for an initial public offering (IPO) with market regulator Sebi.

The size of the public offer is expected to be about Rs5,500 crore.
In the company’s initial public offering, the promoters and existing investors will sell 4 crore shares of equity.
JM Morgan, Citi, Jefferies, Axis, IIFL, and Kotak have been appointed as investment bankers by the business.
Prega News, an emergency contraceptive, Unwanted-21, AcneStar anti-bacterial gel, Ring out the anti-fungal powder, Gas-O-Fast, Kaloree 1 fake sweetener, Heal-O-Kind anti-bacterial ointment, Addiction Deodorant, and KabzEnd are some of the top over-the-counter (OTC) brands for males.
For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • DRHP
  • initial public offering
  • IPO
  • mankind
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.